Physician
Garber, Richard
Garber, Richard was paid $123K by Medicaid between Mar 2018 and Mar 2023, across 17 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 45% of everything it billed.
33Billing provider infoGARBER, RICHARD
FRAMINGHAM, MA 01701
FRAMINGHAM, MA 01701
33aNPI1386637171assigned 08/26/2005
33bProvider typePediatrics Physician
28Total paid$123K
24GClaims3,909
24DCodes billed17
24AFirst – last monthMar 2018 – Mar 2023
Compared with peers
Next to other Pediatrics Physician providers in Massachusetts
Rank by total paid#366 of 1,273
Median peer was paid$24K
This provider vs. median5.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 399 | $11K | |
| 2019 | 571 | $19K | |
| 2020 | 458 | $13K | |
| 2021 | 959 | $32K | |
| 2022 | 1,280 | $40K | |
| 2023 | 242 | $8K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 45% | 961 | 931 | $55K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 19% | 591 | 522 | $23K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 11% | 257 | 253 | $13K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 7.1% | 966 | 959 | $9K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 4.6% | 239 | 233 | $6K |
| 99173 | 2.7% | 151 | 151 | $3K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.4% | 37 | 36 | $3K |
| 96127 | 2.4% | 285 | 285 | $3K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2.3% | 278 | 278 | $3K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.3% | 15 | 13 | $2K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 13 | 13 | $1K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 38 | 38 | $777.10 |
5 more codes
| 0071A | <1% | 12 | $521.16 | |
| 90461 | <1% | 12 | $403.44 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 13 | $402.35 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 27 | $323.27 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 14 | $171.22 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.